Coffee and Type 2 Diabetes: What to Know About Blood Sugar

Last updated: June 2026

Coffee and diabetes risk: what the meta-analyses say

The link between coffee and type 2 diabetes is one of the most heavily studied in nutritional epidemiology. Several meta-analyses pooling dozens of cohort studies converge on the same finding: people who drink coffee regularly tend to have a statistically lower risk of developing type 2 diabetes than non-drinkers.

The relationship is dose-dependent. The Carlström and Larsson meta-analysis (Nutrition Reviews, 2018), which aggregates around thirty studies, reports a risk reduction of about 7 percent per daily cup for caffeinated coffee and 6 percent for decaf, and estimates close to 30 percent lower risk in the heaviest drinkers compared with abstainers. The earlier Huxley et al. meta-analysis (Archives of Internal Medicine, 2009), covering 18 prospective studies, had already established this inverse association, with each extra cup tracking a lower risk.

One essential caveat: these figures come from observational studies. They show an association, not a proven cause-and-effect link. Coffee drinkers differ from non-drinkers in many ways, and even though the analyses adjust for the main confounders, you cannot conclude that drinking more coffee will personally protect any given individual.

Caffeinated versus decaffeinated: a signal beyond caffeine

One result recurs across every review: the benefit also shows up for decaffeinated coffee. Both Huxley et al. and Carlström and Larsson report a risk reduction for decaf, around 6 percent per cup, close to the caffeinated figure.

This parallel has a direct implication. If caffeine were the only active factor, decaf should not show a comparable effect. Yet it does. So the message is reassuring for anyone who tolerates caffeine poorly or prefers to avoid it in the evening: good decaf keeps most of the metabolic interest associated with coffee. Attention then shifts to the other compounds in the bean, polyphenols in particular.

The acute effect of caffeine on blood sugar and insulin sensitivity

There is an apparent paradox. Over the long term, coffee is linked to less diabetes. But in the short term, right after the cup, pure caffeine tends to reduce insulin sensitivity. Trials using an oral glucose tolerance test have measured, after caffeine and compared with placebo, a lower insulin sensitivity index and a higher insulin area under the curve, a sign that the body has to produce more insulin to handle the same glucose load.

The two observations do not really contradict each other. The acute effect measured with isolated caffeine over a few hours is not the effect of whole coffee consumed over years. Coffee also delivers polyphenols that pull in the opposite direction, and the body develops partial tolerance to caffeine. That is probably why, in the studies, caffeinated coffee as a whole does not consistently reproduce the drop in insulin sensitivity seen with pure caffeine.

In practice, two points stand out. First, some people with diabetes may notice a short-lived glycaemic response after a strong coffee. Second, caffeine taken before a blood glucose test can distort the result, so it is better to keep the requested fast without coffee.

The role of chlorogenic acid and polyphenols

Coffee is one of the main dietary sources of chlorogenic acid in the Western diet. This polyphenol is the most studied mechanistic candidate to explain the link between coffee and better glucose regulation.

Several pathways appear in the literature. Chlorogenic acid tends to slow the intestinal absorption of glucose, which flattens the blood-sugar spike after a meal. It is also associated with stimulating the secretion of GLP-1, an incretin hormone that supports an appropriate insulin response, and with activating AMPK in muscle, a pathway tied to glucose uptake. On top of this come the antioxidant and anti-inflammatory effects of coffee polyphenols, relevant for a metabolic disorder marked by low-grade inflammation.

These mechanisms come largely from cell, animal and intermediate-marker studies in humans. They offer a plausible, coherent explanation rather than a full clinical proof. Still, they are enough to explain why decaf, also rich in chlorogenic acid, shares the observed benefit.

The sweetened-coffee trap: syrups, lattes and frappes

Everything above is about coffee as it comes out of the machine, with nothing added. That distinction is crucial. A cup of black coffee carries almost no carbohydrate and does not raise blood sugar by itself. Add sugar, flavoured syrup, sweetened condensed milk or whipped cream, and the profile changes radically.

Some flavoured coffee drinks, sold in large sizes with syrups and sweet toppings, can carry as much sugar as a can of soda. The metabolic benefit attributed to coffee can then be cancelled out, or even reversed, by the added-sugar load. That is often the real risk factor in a cup, not the caffeine.

Practical recommendations

• Favour black or barely sweetened coffee. It is the form consistent with the metabolic data, and the one with no carbohydrate.
• Cut sugar in steps. Reducing by half a sachet per week is more sustainable than quitting abruptly and keeps the enjoyment.
• Watch flavoured drinks. Syrup lattes, frappes and sweet iced coffees concentrate added sugar; treat them like desserts, not like a plain coffee.
• Decaf is a valid option. It keeps the chlorogenic acid and the associated metabolic interest, useful if you are sensitive to caffeine.
• No coffee before a fasting blood test. Caffeine can distort some glucose results.
• Individualise with a clinician. If you have diabetes or prediabetes, discuss any change with a healthcare professional.

Frequently asked questions

Sources

• Carlström M, Larsson SC. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutrition Reviews, 2018.
• Huxley R, Lee CMY, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Archives of Internal Medicine, 2009.
• Ding M, Bhupathiraju SN, Chen M, et al. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a dose-response meta-analysis. Diabetes Care, 2014.
• Research on the acute effect of caffeine on insulin sensitivity during oral glucose tolerance tests, and on chlorogenic acid (glucose absorption, GLP-1, AMPK).